Protalix BioTherapeutics Reports First Quarter 2020 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. RXRX

Go back to Protalix BioTherapeutics Reports First Quarter 2020 Financial Results and Business Update

Protalix BioTherapeutics (PLX) Tops Q1 EPS by 40c, Revenues Beat

June 1, 2020 6:53 AM EDT

Protalix BioTherapeutics (NYSE: PLX) reported Q1 EPS of $0.10, $0.40 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $21.65 million versus the consensus estimate of $6.6 million.

"The first quarter of 2020 has most certainly been transformational for Protalix, despite the COVID-19... More